Review
Copyright ©The Author(s) 2020.
World J Clin Cases. May 26, 2020; 8(10): 1767-1792
Published online May 26, 2020. doi: 10.12998/wjcc.v8.i10.1767
Table 3  In vivo neuroprotective effects and related mechanisms of action of oleanolic acid and its natural and synthetic derivatives (2014-2020)
Disease model/ physiologyEffectMechanism
CompoundDoseRef.
↑↑↑↓↓↓
Focal brain hypoxia (rats)Neuroprotective, IBI, decreased neural damage suppressing glial activitiesS-100b, MAP-2GFAP, NADP-Diaphorase, iNOSOA6 mg/kg·d, 6 d[30]
Parkinsonian model (rats)Prevents AIM, anti-PD, ameliorated dyskinesisCATAffected limbs, AIMs, ROSOA100 mg/kg·2 d, 8 d[31]
Neuro-degeneration (rats, hydroxydopamin)Protects against neurodegenerationCerabral doapamine, contralateral limb useOA100 mg/kg·2 d, 7 d pre or post[32]
Brain damage (rats, fluoride)Brain damageGSH, SOD, CAT, GPX, GST, GRsALT, sAST, LPO, NOOA5 mg/kg·d, last 14 d,[33]
Alzheimer’s disease model (rats, Aβ25-35)Anti-alzheimer, increased synaptic plasticity, decreased Aβ25-35 toxicityNMDAR-2B, CREBCaMKII, PKC, BDNF, TRK-B, Ca2+, Latency timeOA21.6 mg/kg[34]
Rat coronal brain sliceNeuroprotective, anti-alzheimer,BDNFAPP (TAU) toxicity,OA-Xn[35]
Cognitive dysfunction (mice)Ameliorates cognitive dysfunctionpERK-1,2; pCREB, BNDF, TRK-B-OA0.625-5 mg/kg[36]
Chronic unpredictable mild stress (mice)Anti-deprassantpERK-1,2; pCREB, BNDF, miR-132, PSD-95, SYN-1-OA2.5-40 mg/kg·d[37]
Cerabral IRI (mice, PC12 cells)Cerabral protection and prevent IRIBody weights, sTG, pAMPK, pGSK-3β, APN, Adipo-R1, Adipo-R2, pLKB-1, MAOsGLU, sINS, Neurological scores, BAX/BCL2, MDA, TNF-α, IL-6, CASP-3,OA-X (CHS)pretreatment 30,60, 120 mg/kg·d[38]
Exprerimenal stress (mice, corticoid)Anti-depressantAKT/mTOR, BNDFSGK1, GROA10 mg/kg[39]
MiceAnti-depressant-MAO-AOA0.1 mL/10g[40]
MiceAnti-depressantBNDF, sleep durationBehavioral tests, MAOOA5-40 mg/kg[41]